Molecular pharmacology of G protein-coupled receptors.
This themed issue of the British Journal of Pharmacology stems from the eighth in the series of meetings on the Molecular Pharmacology of G protein coupled receptors (MPGPCR) held as part of a joint meeting with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) in Melbourne Australia from 7 to 11 December 2014. Linked Articles This article is part of a themed section on Molecular Pharmacology of G Protein-Coupled Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.20/issuetoc.
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia. roger.summers@monash.edu.
R J
RJ
Summers
D000818:Animals; D055808:Drug Discovery; D006801:Humans; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000378:metabolism
D043562:Receptors, G-Protein-Coupled
Br J Pharmacol. 2016 Oct;173(20):3028-37
26317175
Br J Pharmacol. 2016 Oct;173(20):2952-65
26844674
Br J Pharmacol. 2016 Oct;173(20):3018-27
26276510
Br J Pharmacol. 2016 Oct;173(20):3001-17
26276909
Br J Pharmacol. 2016 Oct;173(20):2966-91
27439627
Br J Pharmacol. 2016 Oct;173(20):2934-51
26837045
Br J Pharmacol. 2016 Oct;173(20):2931-3
27682321
Br J Pharmacol. 2016 Oct;173(20):2992-3000
26624252